Subscribe
All the articles published in this week's magazine in one place
It’s not uncommon for investors to manage money for family and friends, but both sides need to consider the risks of mismanagement and abuse, and how they can be prevented
There are currently more than 300 potential autoimmune drugs in the clinical stage of development, but do any of them hold the key to curing these ferocious illnesses?
Robert Merrifield explains how following one simple rule can flag up the companies that are more likely to wreak havoc on your portfolio than help it
After a decade in the loss-making, scandal-hit wilderness, are the big banks set for a return? And what is to become of the plucky challenger lenders?
Why changes in data protection laws – sparked by the recent Facebook scandal – could have a major impact on the global equities market